% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • rob_cos rob_cos Nov 10, 2011 12:14 PM Flag

    CELG should buy max shrs before ASH/JPM with 8 bill/yr opps

    With 8 billion $ a yr opportunities & CELG able to buy EPS growth at 75% discount - CELG should agressively use the buyback with max buys allowed every day & seriously consider a Dutch Tender like AMGN just announced....

    When I see CELG stock still in the low to mid 60s after ASH abstracts take the SPM issue (that has kept us from running higher) off the table, the pomalidomide update that to me makes Ph 2 approval very likely and the SPM update and MM015 OS trend makes the EU frontline/maintenance approval highly likely – well it screams opportunity to me. Add the early China filing and in my opinion right now we should be trading at $75 based on 2012 earnings. Think this gets there easily after ASH and after JP Morgan Q4 Revlimid disclosure proves the Revlimid Q3 “miss”” was not demand related and JPM Q4 EPS disclosure and 2012 guidance reveals the upside here. Right now CELG has another amazing opportunity to USE THE BUYBACK MORE AGRESSIVELY THAN THEY EVER IMAGINED. The AMGN board and Investment bankers obviously did a lot of analysis and will have 5%+ EPS accretion and they are buying their stock back at a 1.0 PEG and are a slow growth company. CELG impact would be much better. With 2 hours analysis they could see how important aggressive use of the buyback will help this company’s earnings much more than AMGN Dutch tender. BUT THEY NEED TO STRIKE NOW. With 8 to 10 billion dollar a yr opportunities and what they know about Revlimid demand and coming trial results, WHY ARE THEY SAVING any money to buy stock in the 80s next yr when they can get it here.

    Full post here:

    SortNewest  |  Oldest  |  Most Replied Expand all replies
105.83-1.57(-1.46%)Sep 28 4:00 PMEDT